Effects of recombinant human growth hormone on enterocutaneous fistula patients

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 44

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

239

HTML

2207

Figures (1-1)

197

Tables (1-3)

225

Sum=2868

Nov 28, 2008 (publication date) through Jan 12, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Nov 28, 2008; 14(44): 6858-6862
Published online Nov 28, 2008. doi: 10.3748/wjg.14.6858

Table 1 General state of the patients

Age (Yr)	Sex	Weight (kg)	Distance from ligament of tretiz (cm)	Rest energy expenditure (KJ)	Enteral nutrition energy (KJ)
65	F	52	40	4276	6276
42	M	68	80	5648	8368
30	M	80	100	6192	9205
32	M	61	120	4384	6276
18	M	48	60	4322	6276
72	F	56	90	5773	8368
38	M	77	135	6158	9205
27	F	49	85	4359	6276

Citation: Gu GS, Ren JA, Li N, Li JS. Effects of recombinant human growth hormone on enterocutaneous fistula patients. World J Gastroenterol 2008; 14(44): 6858-6862
URL: https://www.wjgnet.com/1007-9327/full/v14/i44/6858.htm
DOI: https://dx.doi.org/10.3748/wjg.14.6858